Skip to main content

Table 1 Clinical and pathological features of samples included in the study

From: Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation

 

TACE (n = 16)

No-TACE (n = 23)

P value

Age (years)

56(48–68)

55(45–68)

0.363

Gender (F/M)

2/14

5/18

0.460

AFP (ng/ml)

660(3–7245)

382(3–2809)

0.114

Tumor Num. (Single/Multiple)

8/8

14/9

.0.365

Largest Tumor size Mean (range) (mm)

38 (20–76)

29(3–60)

0.069

Differentiation

  

0.156

Well

1

7

 

Moderately

12

14

 

Poor

3

2

 

TNM Stage

  

0.365

I

8

14

 

II

8

9